Pharma Reviews: Govt incentives will help Indian pharma cos reduce API imports from China: Tata Mutual Fund

Do you think that could be a bit of a hurdle for Indian pharmaceutical companies and how would you position yourselves among companies that have ...
Read more: Govt incentives will help Indian pharma cos reduce API imports from China: Tata Mutual Fund

Pharma Reviews: AIIMS RDA calls for setting up of Indian Medical Service

Subscribe to our Newsletters. 125000+ Industry Leaders read it everyday.
Read more: AIIMS RDA calls for setting up of Indian Medical Service

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup June 30, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup June 30, 2020

Pharma Reviews: How is the Indian pharmaceutical industry different from its Western counterparts

No other company is allowed to either manufacture or market these medicines. Medical practitioners prescribe the patented drug as per the brand name.
Read more: How is the Indian pharmaceutical industry different from its Western counterparts

US FDA News: Coronavirus (COVID-19) Update: FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines

The FDA is taking important action to help facilitate the timely development of safe and effective vaccines to prevent COVID-19 by providing guidance with recommendations for those developing COVID-19 vaccines.
Read more: Coronavirus (COVID-19) Update: FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines

Pharma Reviews: Chinese import restrictions: Pharma companies seek more time to meet export orders from foreign ...

Indian businesses continue to face hurdles due to import restrictions on consignments of Chinese origin. Some of the worst-hit sectors such as ...
Read more: Chinese import restrictions: Pharma companies seek more time to meet export orders from foreign ...

Pharma Reviews: After lockdown punch, Indian companies are hit by Chinese shipments stuck at ports

From active pharmaceutical ingredients that go into the world's most-consumed drugs to the innards of popular mobile phones, Indian companies ...
Read more: After lockdown punch, Indian companies are hit by Chinese shipments stuck at ports

Pharma Reviews: Manufacture of vaccines in India

This is where India can be a major player. Being the largest provider of generic drugs worldwide, the Indian pharmaceutical sector meets close to 50 ...
Read more: Manufacture of vaccines in India

Pharma Reviews: Active Pharmaceutical Ingredients: How dependent is India on China

At least 60% of India's Active Pharmaceutical Ingredient (API) requirements come from China. ET's Divya Rajagopal takes a look at how the Indian ...
Read more: Active Pharmaceutical Ingredients: How dependent is India on China

Pharma Reviews: Covaxin: India's first COVID19 vaccine candidate from Bharat Biotech to begin human trials; check ...

Health agencies and pharmaceutical companies across the world are racing against the time to develop an effective vaccine that can curb the spread of ...
Read more: Covaxin: India's first COVID19 vaccine candidate from Bharat Biotech to begin human trials; check ...

Pharma Reviews: Pharma body seeks faster clearances of imported good at ports

During current distressed and challenging times of global COVID-19 pandemic, the pharmaceutical industry of India has risen to meet the challenges ...
Read more: Pharma body seeks faster clearances of imported good at ports

Pharma Reviews: Auto, pharma sectors seek immediate clearance of imports

India's auto industry in dependent on China for crucial parts and a delay at this point of time will impact the sector which is showing early signs of ...
Read more: Auto, pharma sectors seek immediate clearance of imports

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup June 29, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup June 29, 2020

US FDA News: FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer

FDA approves Keytruda for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer.
Read more: FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer

US FDA News: UVT, INC. Issues Voluntary Nationwide Recall of SANIDERM ADVANCED HAND SANITIZER Due to the Potential Presence of Undeclared Methanol (Wood Alcohol)

UVT, INC. is voluntarily recalling 38,830 liters of SANIDERM ADVANCED HAND SANITIZER, packaged in 1-liter bottles to the consumer level. The products are being recalled due to the potential presence of methanol (wood alcohol)

Read more: UVT, INC. Issues Voluntary Nationwide Recall of SANIDERM ADVANCED HAND SANITIZER Due to the Potential Presence of Undeclared Methanol (Wood Alcohol)

US FDA News: FDA Approves Breast Cancer Treatment That Can Be Administered At Home By Health Care Professional

FDA approves Phesgo to treat adult patients with HER2-positive breast cancer. Phesgo can be administered at home by a health care professional once chemotherapy is finished.
Read more: FDA Approves Breast Cancer Treatment That Can Be Administered At Home By Health Care Professional

Pharma Reviews: Mylan's imported inputs for corona drugs stuck at Mumbai Air Cargo Complex

The Pharmaceutical Export Promotion Council of India (Pharmexcil) has written to the Centre to seek urgent customs clearance for imported goods as ...
Read more: Mylan's imported inputs for corona drugs stuck at Mumbai Air Cargo Complex

Pharma Reviews: Indian pharma industry is strategically placed to cater to the COVID-19 crisis

How important is the Indian market for Enterprise Ireland? India is classified as a 'high growth market' by Enterprise Ireland, while the majority of the ...
Read more: Indian pharma industry is strategically placed to cater to the COVID-19 crisis

Pharma Reviews: Ingredients for COVID-19 drugs remdesivir, favipiravir stuck amid import logjam

Ramu Deora, former president of the Federation of Indian Export Organisations (FIEO), told CNBC-TV18, "A lot of critical pharma manufacturing raw ...
Read more: Ingredients for COVID-19 drugs remdesivir, favipiravir stuck amid import logjam

Pharma Reviews: Chinese imports held at ports to soon hit Indian pharma companies

New Delhi: Chinese consignments being held at Indian ports by custom authorities may soon come to haunt the Indian pharmaceutical industry ...
Read more: Chinese imports held at ports to soon hit Indian pharma companies

Pharma Reviews: Can't make Indian manufacturing globally competitive by imposing tariff barriers: Pawan Goenka

If I look at the Indian manufacturing sector which you proudly represent, there have been only two success stories: autos/auto ancillary and pharma.
Read more: Can't make Indian manufacturing globally competitive by imposing tariff barriers: Pawan Goenka

Pharma Reviews: Pharma companies send SOS to govt to clear stuck imports from China

Pharmaceutical Export Promotion Council of India (Pharmexcil) informed the government that member companies have sent them distress calls over ...
Read more: Pharma companies send SOS to govt to clear stuck imports from China

Pharma Reviews: Market LIVE: Sensex, Nifty fall; metal, auto stocks, banks under pressure

Pharma industry seeks urgent govt intervention on stuck Chinese imports: CNBC TV18. The Indian pharmaceutical industry has sought urgent ...
Read more: Market LIVE: Sensex, Nifty fall; metal, auto stocks, banks under pressure

Pharma Reviews: Geography, economics, history, and culture: Here's why India and China need each other

Listen to the cries of job creators in India – right from pharma sector companies to automobile players – that a ban on Chinese products will mean ...
Read more: Geography, economics, history, and culture: Here's why India and China need each other

Pharma Reviews: Market LIVE Updates: Indices off day's low; FMCG in focus, metals lose shine

Sun Pharmaceutical Industries' wholly-owned subsidiary has received ... shed 3.5 percent led by the UCO Bank, Bank of Baroda, Union Bank of India:.
Read more: Market LIVE Updates: Indices off day's low; FMCG in focus, metals lose shine

Pharma Reviews: Piramal share price falls despite Carlyle stake buy; should you buy the stock? Check upside target

The transaction is one of the largest private equity deals in Indian pharmaceutical industry, which values the pharma business at an enterprise value of ...
Read more: Piramal share price falls despite Carlyle stake buy; should you buy the stock? Check upside target

Pharma Reviews: Market Update: Sensex slips 329.16 pts to 34842.11 in opening session; Nifty falls 91.50 pts to ...

Earlier, six of the 10 most valued Indian companies together added Rs ... Listen to the cries of job creators in India – right from pharma sector ...
Read more: Market Update: Sensex slips 329.16 pts to 34842.11 in opening session; Nifty falls 91.50 pts to ...

Pharma Reviews: Petrol, diesel prices hiked again after a day's pause

According to the official website of Indian Oil Corporation, petrol now costs Rs ... Listen to the cries of job creators in India – right from pharma sector ...
Read more: Petrol, diesel prices hiked again after a day's pause

Pharma Reviews: Private Equity Major Carlyle To Buy 20 Per Cent Stake In Piramal Pharma For $490 Million

Once completed, the transaction would mark the biggest private equity deal in the Indian pharmaceutical industry. Piramal Pharma has been in ...
Read more: Private Equity Major Carlyle To Buy 20 Per Cent Stake In Piramal Pharma For $490 Million

Pharma Reviews: Carlyle Group to buy 20% stake in Piramal Pharma for about Rs 3700 cr

This transaction is one of the largest private equity deals in the Indian pharmaceutical sector, and is expected to close in 2020, subject to customary ...
Read more: Carlyle Group to buy 20% stake in Piramal Pharma for about Rs 3700 cr

Pharma Reviews: Indian Pharma Industries likely to continue Chinese imports till feasible alternatives emerge

... for the time being till other feasible and cost-effective alternatives emerge, according to players in Indian automobile and pharmaceutical industries.
Read more: Indian Pharma Industries likely to continue Chinese imports till feasible alternatives emerge

Pharma Reviews: Explained: Will banning Chinese imports hurt India's exports?

Across sectors from pharmaceuticals to telecommunications and automobiles, industry associations have been speaking up against a complete ...
Read more: Explained: Will banning Chinese imports hurt India's exports?

Pharma Reviews: Bulk drug manufacturers seek support from govt, regulatory authorities

Arjun Juneja, Director, Mankind Pharma commented, “To make the Indian API industry competitive and self-reliant, there is a need to initiate strategic ...
Read more: Bulk drug manufacturers seek support from govt, regulatory authorities

US FDA News: Saniderm Products Voluntarily Issues Regional (Virginia, Maryland, New Jersey) Recall of 1 L Saniderm Advanced Hand Sanitizer bottles produced by Eskbiochem SA de CV Due to the Potential Presence of Undeclared Methanol (Wood Alcohol)

Saniderm Products (Saniderm) is voluntarily recalling Saniderm Advanced Hand Sanitizer, packaged in 1-liter bottles to the consumer level. The products are being recalled due to the potential presence of methanol (wood alcohol). In response to a recent news alert by the Food and Drug Administration
Read more: Saniderm Products Voluntarily Issues Regional (Virginia, Maryland, New Jersey) Recall of 1 L Saniderm Advanced Hand Sanitizer bottles produced by Eskbiochem SA de CV Due to the Potential Presence of Undeclared Methanol (Wood Alcohol)

Pharma Reviews: IOL Chemical has lined-up an annual CapEx of Rs 150-200 for the next three years: Vijay Garg, JMD

So, these are very good steps that the government of India is taking. Now, the Pharma industry is coming forward that is why I think that our dependency ...
Read more: IOL Chemical has lined-up an annual CapEx of Rs 150-200 for the next three years: Vijay Garg, JMD

Pharma Reviews: Carlyle Group to buy 20 pc stake in Piramal Pharma for over Rs 3700 cr

Carlyle has a history of investing in the healthcare sector, both in India and globally. It had in May announced a majority stake investment in Indian ...
Read more: Carlyle Group to buy 20 pc stake in Piramal Pharma for over Rs 3700 cr

Pharma Reviews: Supply Chain Labs and QGLUE Launch the Healthcare and Pharma Supply Chain Innovation Forum

Decoding the impact of COVID-19 on Healthcare & Pharma sector – global ... The initiative is done in partnership with Indian Angel Network, Idemia, ...
Read more: Supply Chain Labs and QGLUE Launch the Healthcare and Pharma Supply Chain Innovation Forum

Pharma Reviews: India's auto and pharma sectors not ready to wean off China

Some of India's largest drug companies, such as Sun Pharmaceutical Industries , Lupin and IPCA Labs , rely on China, and India overall gets about ...
Read more: India's auto and pharma sectors not ready to wean off China

Pharma Reviews: Solving The Mysteries Between The Branded Drugs Vs The Generic Drugs

THE INDIAN PHARMA MARKET: India is one of the largest producers of generic drugs globally. The Indian pharmaceutical sector industry supplies over ...
Read more: Solving The Mysteries Between The Branded Drugs Vs The Generic Drugs

Pharma Reviews: Carlyle to acquire 20% stake in Piramal's pharma business for ₹3700 crore

The company had sold almost all of its domestic pharma business to Abbott in ... Carlyle's investments in the Indian healthcare sector include Medanta ...
Read more: Carlyle to acquire 20% stake in Piramal's pharma business for ₹3700 crore

Pharma Reviews: Carlyle to pick 20% stake in Piramal Pharma for USD 490 million

According to prices given by the Indian Bullion and Jewellers Association, a Mumbai-based industry body, on June 26, the rate without GST for gold ( ...
Read more: Carlyle to pick 20% stake in Piramal Pharma for USD 490 million

Pharma Reviews: Exit the Dragon: India can afford to boycott Chinese products

Accordingly, industry and trade experts contended that a move to fully ... India depends on China in electronics, machinery, pharma, chemicals, ...
Read more: Exit the Dragon: India can afford to boycott Chinese products

Pharma Reviews: Drug makers urge Commerce Ministry to clear stuck imports

India's imports of pharmaceutical products from China increased 28% to Rs 1,150 crore in 2019-20 from Rs 947 crore in 2015-16. This figure excludes ...
Read more: Drug makers urge Commerce Ministry to clear stuck imports

Pharma Reviews: Supply Chain Labs and QGLUE launch the Healthcare and Pharma Supply Chain Innovation Forum

Decoding the impact of COVID-19 on Healthcare & Pharma sector - global ... The initiative is done in partnership with Indian Angel Network, Idemia, ...
Read more: Supply Chain Labs and QGLUE launch the Healthcare and Pharma Supply Chain Innovation Forum

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup June 26, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup June 26, 2020

Pharma Reviews: Dev 360 | Medicine and frontiers: The challenge that China poses

“The Indian pharmaceutical industry, especially our bulk drug industry, was well ... “Indian pharma companies who were manufacturing penicillin and ...
Read more: Dev 360 | Medicine and frontiers: The challenge that China poses

Pharma Reviews: Trade bodies say need time to stop reliance on imports from China

From pharmaceuticals to telecommunications and automobiles, industry associations ... Our goals include strengthening those sectors in India through ...
Read more: Trade bodies say need time to stop reliance on imports from China

Pharma Reviews: Chinese imports likely to continue till feasible alternatives emerge: Auto, Pharma players

Indian auto and pharma industries import several critical components and raw materials from China. Currently, companies based out of China continue ...
Read more: Chinese imports likely to continue till feasible alternatives emerge: Auto, Pharma players

Pharma Reviews: Pharma cos should develop strategies to develop APIs and making India self-reliant: Dr Eswara ...

In line with making Indian pharmaceutical industry self-reliant for active pharmaceutical ingredients (APIs) and key starting materials (KSMs), ...
Read more: Pharma cos should develop strategies to develop APIs and making India self-reliant: Dr Eswara ...

Pharma Reviews: Chinese Parts Fuel Indian Auto & Pharma Sector, Industry Raises Concern on Import Ban

India sources electronic components and drug ingredients from China. These are not available elsewhere at the cheap prices that China offers.
Read more: Chinese Parts Fuel Indian Auto & Pharma Sector, Industry Raises Concern on Import Ban

Pharma Reviews: SUN Mobility partners with Indian Oil Corporation Limited to launch battery-swapping station

As the company claims, Indian Oil Corporation will set up the battery ... the oil marketing companies had worked together to usher in BS-VI fuels across ...
Read more: SUN Mobility partners with Indian Oil Corporation Limited to launch battery-swapping station

Pharma Reviews: Dev 360 | Medicine and frontiers: The challenge that China poses

This is more so in the pharmaceutical industry, where the stakes are a matter of life and death. Indians have woken up to the other side of the “India as a ...
Read more: Dev 360 | Medicine and frontiers: The challenge that China poses

Pharma Reviews: Replacing China as API supplier for pharma will be a medium to long term story: Lupin

The Indian pharmaceutical industry is well poised for growth for some time to come. -Ramesh Swaminathan, Lupin. Likewise, Mylan which had a market ...
Read more: Replacing China as API supplier for pharma will be a medium to long term story: Lupin

Pharma Reviews: Chinese imports likely to continue till feasible alternatives emerge: Auto, pharma companies

Indian auto and pharma industries import several critical components and raw ... When asked to comment on the pharma sector, India Pharmaceutical ...
Read more: Chinese imports likely to continue till feasible alternatives emerge: Auto, pharma companies

Pharma Reviews: Enemies with benefits

The thriving Indian pharmaceutical industry is heavily dependent on critical components from China. As the brutal killing of 20 Indian Army ...
Read more: Enemies with benefits

Pharma Reviews: India's auto, pharma sectors not ready to wean off China

But two big industries, automobiles and pharmaceuticals, say this is easier said than done. Like many countries, India relies on China for products ...
Read more: India's auto, pharma sectors not ready to wean off China

Pharma Reviews: Imports from China likely to continue until feasible, cost effective alternatives emerge

Indian auto and pharma industries import several critical components and raw materials from China. Currently, companies based out of China ...
Read more: Imports from China likely to continue until feasible, cost effective alternatives emerge

Pharma Reviews: The Evolution of Product Planning in Post Covid-19 World

Conceiving and creating vehicles specifically for the Indian customer became ... Also Read: ETAuto Originals: An anatomy of the Indian auto industry.
Read more: The Evolution of Product Planning in Post Covid-19 World

Pharma Reviews: Supply Chain Labs and QGLUE Launch the Healthcare and Pharma Supply Chain Innovation Forum

An initiative to help healthcare and pharma companies optimize their ... Supply Chain Labs by Lumis Partners is India's largest platform connecting ...
Read more: Supply Chain Labs and QGLUE Launch the Healthcare and Pharma Supply Chain Innovation Forum

Pharma Reviews: Auto, pharma sectors not ready to wean off China

Some of India's largest drug companies, such as Sun Pharmaceutical Industries , Lupin and IPCA Labs, rely on China, and India overall gets about 70% ...
Read more: Auto, pharma sectors not ready to wean off China

Pharma Reviews: Government may review customs checks on Chinese goods

Samsung, and many other Indian vendors are also impacted, an industry ... Electronics and pharma are two sectors that depend heavily on Chinese ...
Read more: Government may review customs checks on Chinese goods

Pharma Reviews: Strained India-China Relations May Increase Supply Chain Risks

The most affected sectors could be Auto, Consumer Durables, Pharmaceuticals, Telecom, Chemicals and Renewable Power sector (Solar) that seem to ...
Read more: Strained India-China Relations May Increase Supply Chain Risks

Pharma Reviews: Stocks To Watch: Ashok Leyland, Coal India, Dewan Housing Finance, GATI, Glenmark Pharma ...

The company will invest close to Rs 3,800 crore in the Phase I of this ... Glenmark Pharmaceuticals; Adhunik Industries; APL Apollo Tubes; Oil India ...
Read more: Stocks To Watch: Ashok Leyland, Coal India, Dewan Housing Finance, GATI, Glenmark Pharma ...

Pharma Reviews: India's auto and pharma sectors not ready to wean off China

But two big industries, automobiles and pharmaceuticals, say this is easier said than done. Like many countries, India relies on China for products such ...
Read more: India's auto and pharma sectors not ready to wean off China

US FDA News: FDA Approves New Therapy for Dravet Syndrome

FDA approves Fintepla (fenfluramine), a Schedule IV controlled substance, for the treatment of seizures associated with Dravet syndrome in patients age 2 and older. Dravet syndrome is a life-threatening, rare and chronic form of epilepsy.
Read more: FDA Approves New Therapy for Dravet Syndrome

Pharma Reviews: Gated Globalization or Re-Globalization: What India should aim for?

USA has made a clarion call for certain industries being completely indigenous; pharma, aerospace, defence and electronics, being the first and ...
Read more: Gated Globalization or Re-Globalization: What India should aim for?

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup June 25, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup June 25, 2020

Pharma Reviews: India's auto and pharma sectors not ready to wean off China

But two big industries, automobiles and pharmaceuticals, say this is easier said than done. FILE PHOTO: Workers assemble a Tata Tigor car inside the ...
Read more: India's auto and pharma sectors not ready to wean off China

Pharma Reviews: India's auto and pharma sectors not ready to wean off China

Some of India's largest drug companies, such as Sun Pharmaceutical Industries, Lupin and IPCA Labs, rely on China, and India overall gets about ...
Read more: India's auto and pharma sectors not ready to wean off China

Pharma Reviews: COVID-19: Hetero releases generic Remdesivir 'Covifor', check cost per injection

Coronavirus treatment in India: Hetero Pharma starts supplying generic ... On Wednesday, Indian generic pharmaceutical giant Hetero announced that ...
Read more: COVID-19: Hetero releases generic Remdesivir 'Covifor', check cost per injection

Pharma Reviews: Pharma: Is the show over or are there some fireworks left?

The Indian pharma sector is well-diversified in which large players concentrate on exports while other companies cater to domestic demand, including ...
Read more: Pharma: Is the show over or are there some fireworks left?

Pharma Reviews: Sectors, Stocks Most Exposed To India-China Trade Links, According To Motilal Oswal

Sectorally, automobiles, consumer durables, pharmaceuticals, telecom, chemicals and the renewable energy (solar) sectors seem to be the most ...
Read more: Sectors, Stocks Most Exposed To India-China Trade Links, According To Motilal Oswal

Pharma Reviews: Consignments from China piling up at ports as customs tightens scrutiny

India China standoff live updates. For instance, a ... With major shipments stuck at ports and airports, pharma industry pressed the panic button. Critical ...
Read more: Consignments from China piling up at ports as customs tightens scrutiny

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup June 24, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup June 24, 2020

US FDA News: Chengdu Ai Qin E-Commerce Co., Ltd Issues Nationwide Recall of TTDEYE Brand Colored Contact Lenses

On June 18, 2020, Chengdu Ai Qin E-commerce Co., Ltd initiated a nationwide recall of 1362 pairs of colored contact lenses. The relevant series of contact lenses have been found to be distributed without FDA clearance and may pose a threat to health.
Read more: Chengdu Ai Qin E-Commerce Co., Ltd Issues Nationwide Recall of TTDEYE Brand Colored Contact Lenses

Pharma Reviews: 'Boycott China' to have side-effects on pharma

The Indian pharmaceutical industry is the third-largest in the world by volume. In terms of value, it is ranked 13. India accounts for 60 per cent of the ...
Read more: 'Boycott China' to have side-effects on pharma

US FDA News: Coronavirus (COVID-19) Update: Joint Statement from USDA and FDA on Food Export Restrictions Pertaining to COVID-19

U.S. Secretary of Agriculture Sonny Perdue and FDA Commissioner Stephen M. Hahn, M.D., issued the following statement regarding food export restrictions pertaining to COVID-19.
Read more: Coronavirus (COVID-19) Update: Joint Statement from USDA and FDA on Food Export Restrictions Pertaining to COVID-19

Pharma Reviews: Indian media's hustle for Big Pharma bares conflicts of interest

Apart from Jubilant, four Indian generic pharmaceutical manufacturers have so far been licenced to make the drug: Dr Reddy's Labs, Cipla Ltd, Hetero ...
Read more: Indian media's hustle for Big Pharma bares conflicts of interest

Pharma Reviews: Market LIVE: Sensex, Nifty down over 1% each; Asian Paints, ITC hold on to gains

Over 2 lakh coronavirus tests conducted in last 24 hours, the Indian Council of Medical Research (ICMR) said on Wednesday. Total number of cases ...
Read more: Market LIVE: Sensex, Nifty down over 1% each; Asian Paints, ITC hold on to gains

Pharma Reviews: MARKET LIVE: Indices regain momentum; Sensex up 150 pts; PSBs gain

Today, a total of 85 companies, including the likes of Canara Bank, Indian Oil Corporation, GAIL, ... The key factor is the drug major's strong outlook.
Read more: MARKET LIVE: Indices regain momentum; Sensex up 150 pts; PSBs gain

Pharma Reviews: India's medical needs: Global collaboration matters now more than ever

While the self-reliant model seems promising, it is important to note the role of the global industry, which, so far, has catered to 70% of India's medical ...
Read more: India's medical needs: Global collaboration matters now more than ever

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup June 23, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup June 23, 2020

US FDA News: FDA Announces First of Its Kind Pilot Program to Communicate Patient Reported Outcomes from Cancer Clinical Trials

FDA launches Project Patient Voice, an initiative of the FDA’s Oncology Center of Excellence. Project Patient Voice creates a consistent source of publicly available information describing patient-reported symptoms from cancer trials for marketed treatments.
Read more: FDA Announces First of Its Kind Pilot Program to Communicate Patient Reported Outcomes from Cancer Clinical Trials

Pharma Reviews: Coronavirus vaccine, drug update: Patanjali launches 'Coronil'; Hetero, Cipla get nod to sell ...

Meanwhile, some Indian pharma firms have launched antiviral drugs in the Indian market. Here are the latest updates on COVID-19 vaccine, drug:.
Read more: Coronavirus vaccine, drug update: Patanjali launches 'Coronil'; Hetero, Cipla get nod to sell ...

Pharma Reviews: India needs to revolutionise drug research with AI: Dassault Systemes

The pharma segment of the event covered topics like digital continuity in the pharmaceutical industry, revolutionising the drug development process with ...
Read more: India needs to revolutionise drug research with AI: Dassault Systemes

Pharma Reviews: Indian ancillary manufacturers assure uninterrupted supply of materials related to COVID-19 vaccine

Alagu Subramaniam, Managing Director, West Pharmaceutical Packaging India, said, “As a leading solution provider of drug manufacturers and delivery ...
Read more: Indian ancillary manufacturers assure uninterrupted supply of materials related to COVID-19 vaccine

Pharma Reviews: Telecom and pharma top sectoral bets in this market: Axis Capital

We have about 45 companies participating now; broadly about 20% of the India market cap across sectors. This is not focussed on a particular sector.
Read more: Telecom and pharma top sectoral bets in this market: Axis Capital

Pharma Reviews: Market LIVE Updates: Indices at day's high; L&T, IndusInd Bank top gainers

The company is one of India's leading automotive component manufacturers with operations in India and Europe. It mainly caters to two and ...
Read more: Market LIVE Updates: Indices at day's high; L&T, IndusInd Bank top gainers

Pharma Reviews: Depending on China for imports could threaten India's drug security: Export council DG

“The pandemic is an eye-opener for the pharma industry, which is heavily dependent on China for the active pharmaceutical ingredients and key ...
Read more: Depending on China for imports could threaten India's drug security: Export council DG

Pharma Reviews: Favipiravir for Coronavirus treatment: Check how Glenmark's Covid-19 medicine FabiFlu works

India's drug regulator--Drugs Controller General of India (DCGI) had ... With the DGCI's nod, Glenmark became the first Indian pharma company to ...
Read more: Favipiravir for Coronavirus treatment: Check how Glenmark's Covid-19 medicine FabiFlu works

Pharma Reviews: Government to curb pharma imports from China

The domestic API manufacturing industry, mostly based out of Hyderabad and Ahmedabad, currently accounts for 8-10% of India's over Rs 1.33 lakh ...
Read more: Government to curb pharma imports from China

Pharma Reviews: Trending stocks: Glenmark Pharma shares slip nearly 6%

Shares of the company of Glenmark Pharmaceuticals Ltd. quoted a ... Glenmark Pharmaceuticals Ltd. belongs to the Pharma - Indian industry.
Read more: Trending stocks: Glenmark Pharma shares slip nearly 6%

Pharma Reviews: Coronavirus vaccine update: Patanjali to launch ayurvedic medicine today

Last month, global pharmaceutical major Pfizer said it believed a vaccine to prevent Covid-19 could be ready by the end of October. ... will now be available in the Indian market under the brand name FabiFlu at Rs 103 per tablet.
Read more: Coronavirus vaccine update: Patanjali to launch ayurvedic medicine today

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup June 22, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup June 22, 2020

Pharma Reviews: Glimmer of hope: 3 Indian pharmaceutical companies get DGCI nod for Covid-19 drugs

While a pall of gloom has fallen over the country, all thanks to Covid-19, the search for a magic drug by Indian pharma companies bring a glimmer of ...
Read more: Glimmer of hope: 3 Indian pharmaceutical companies get DGCI nod for Covid-19 drugs

Pharma Reviews: COVID-19 exposed dependence of world, India on China for active pharma ingredients

Chinese dominance in the pharmaceutical sector has been questioned across ... API manufacturing in India can reduce costs for US and European ...
Read more: COVID-19 exposed dependence of world, India on China for active pharma ingredients

Pharma Reviews: Fabiflu, Covifor, Cipremi and other drugs approved or under trial for COVID-19 patients in India

There is some good news for Indians — medicines showing promising results to treat coronavirus. India's pharmaceutical companies like Glenmark, ...
Read more: Fabiflu, Covifor, Cipremi and other drugs approved or under trial for COVID-19 patients in India

Pharma Reviews: Pharma powers Indian shares to three-month closing high

Indian shares closed at a three-month high on Monday as domestic regulatory approvals to manufacture COVID-19 drugs lifted pharmaceutical stocks, ...
Read more: Pharma powers Indian shares to three-month closing high

Pharma Reviews: COVID India: Cipla to Sell Antiviral Drug Remdesivir as 'Cipremi'

In May, Gilead Sciences signed non-exclusive voluntary licensing agreements with six Indian pharmaceutical companies to boost the supply of ...
Read more: COVID India: Cipla to Sell Antiviral Drug Remdesivir as 'Cipremi'

Pharma Reviews: Coronavirus vaccine update: Favipiravir hits Indian market; Remedesivir gets DCGI nod

Biotechnology and pharmaceutical firms comprising Moderna Inc, and AstraZeneca, have been accelerating the pace of their production, promising ...
Read more: Coronavirus vaccine update: Favipiravir hits Indian market; Remedesivir gets DCGI nod

Pharma Reviews: Sensex ends 180 points higher, Nifty above 10300; Banks, pharma stocks rally

Market Closing. Indian benchmark equity indices closed over 0.5% higher on Monday, led by healthy buying in banks, metals and pharma stocks.
Read more: Sensex ends 180 points higher, Nifty above 10300; Banks, pharma stocks rally

Pharma Reviews: Stock Market Highlights: Sensex ends 179 points higher, Nifty above 10300; financials, pharma ...

Stock Market Highlights: India shares ended higher on Monday as gains in pharma and financial companies outweigh the impact of a record surge in ...
Read more: Stock Market Highlights: Sensex ends 179 points higher, Nifty above 10300; financials, pharma ...

Pharma Reviews: IPA launches a digital campaign to ensure uninterrupted medicines supply during COVID-19 ...

Indian Pharmaceutical Alliance (IPA), that represents 25 research-based pharmaceutical companies in India, announced the launch of their digital ...
Read more: IPA launches a digital campaign to ensure uninterrupted medicines supply during COVID-19 ...

Pharma Reviews: Indian Pharmaceutical Alliance launches “Mission Medicine- Delivering Life”

The entire supply chain of the pharmaceutical industry has been continuously working to provide medicines during the lockdown period and beyond.
Read more: Indian Pharmaceutical Alliance launches “Mission Medicine- Delivering Life”

Pharma Reviews: Glenmark says FabiFlu reduces viral load by 4 days, treats mild to moderate COVID-19 patients

Glenmark first pharmaceutical company in India to receive approval. Glenmark filed the product for a clinical trial with India's drug regulator DCGI and ...
Read more: Glenmark says FabiFlu reduces viral load by 4 days, treats mild to moderate COVID-19 patients

Pharma Reviews: Select large-caps hit record highs as Street prefers strong fundamentals

The company reported a net profit in the March quarter after a series of ... a bid from the Solar Energy Corporation of India to develop eight gigawatts of solar ... There are three pharma companies in the sample of 10 including Biocon, ...
Read more: Select large-caps hit record highs as Street prefers strong fundamentals

Pharma Reviews: 'Boycott China' easier said than done, say Telangana industry experts

'Boycott China' easier said than done, say Telangana industry experts ... sector in Telangana's industry pie chart may be small, pharma sector has a ... Chinese goods in the wake of ongoing hostility between India and China, it is ...
Read more: 'Boycott China' easier said than done, say Telangana industry experts

Pharma Reviews: Cutting China ties not easy, drug imports up 28% since Doklam

Mumbai: India's aspiration to reduce its dependency on China in the pharmaceutical sector has remained on paper so far, show figures. During the ...
Read more: Cutting China ties not easy, drug imports up 28% since Doklam

Pharma Reviews: Coronavirus: Pharma firm Hetero gets drug controller's nod to produce, market remdesivir

Indian pharmaceutical firm Hetero announced on Sunday that it has received approval from the Drug Controller General of India to both manufacture ...
Read more: Coronavirus: Pharma firm Hetero gets drug controller's nod to produce, market remdesivir

Pharma Reviews: Cipla, Hetero get nod to manufacture, sell Remdesivir drug to fight COVID-19

In a significant development, India's top drug regulator has given nod to two domestic pharmaceutical companies--Cipla and Hetero for marketing ...
Read more: Cipla, Hetero get nod to manufacture, sell Remdesivir drug to fight COVID-19

Pharma Reviews: Boycott China comes with a cost, say MSMEs

Industry bodies such as Federation of Indian Micro and Small & Medium ... SME Chamber of India and All India Manufacturers Organisation (AIMO) ... For the pharma sector, too, India imports two-thirds of its active pharmaceutical ...
Read more: Boycott China comes with a cost, say MSMEs

Pharma Reviews: Petrol and diesel prices hiked for 15th consecutive day

According to the official website of Indian Oil Corporation, petrol now costs ... Ram Singh Rathor of Shield Armoring, a Mumbai-based company that ... Pharma Solutions to acquire G&W Laboratories' drug manufacturing facility in US.
Read more: Petrol and diesel prices hiked for 15th consecutive day

Pharma Reviews: The future of vehicles: More private cars looking at bulletproof options for added security and safety

It had then filed the product for clinical trial with country's drug regulator DCGI and became the first pharmaceutical company in India to receive approval ...
Read more: The future of vehicles: More private cars looking at bulletproof options for added security and safety

Pharma Reviews: Petrol and diesel prices hiked for 14th consecutive day; petrol price up by 51 paise, diesel by 61 ...

According to the official website of Indian Oil Corporation, petrol now costs Rs ... The drug firm had successfully developed the active pharmaceutical ...
Read more: Petrol and diesel prices hiked for 14th consecutive day; petrol price up by 51 paise, diesel by 61 ...

Pharma Reviews: The death of Indian soldiers in skirmish with China raises questions on trade, geopolitics ...

Any supply disruption would hurt India's $39 billion pharma industry, the world's third largest drug producer (by volume). About 27% of auto component ...
Read more: The death of Indian soldiers in skirmish with China raises questions on trade, geopolitics ...

Pharma Reviews: India: A global nutraceutical hub in the making

The discoveries of those times evolved into a convergence of allied fields like biotechnology, agrotech, chemical engineering, pharmaceutical ...
Read more: India: A global nutraceutical hub in the making

Pharma Reviews: Pharma firms in U'khand say suppliers hiking prices of Chinese raw materials after Galwan clash

Amid calls of 'Boycott China' after the killing of 20 Indian Army soldiers in ... Most of the raw material for the pharmaceutical industry is imported from ...
Read more: Pharma firms in U'khand say suppliers hiking prices of Chinese raw materials after Galwan clash

Pharma Reviews: India can take on China in API sector but not without govt easing regulation, say pharma giants

The manufacture of drugs in India, many life-saving, is dependent on sourcing raw material or active pharmaceutical ingredients (APIs) from China.
Read more: India can take on China in API sector but not without govt easing regulation, say pharma giants

Pharma Reviews: Glenmark drug for mild Covid patients hits market, priced at Rs 103 a pill

Oral antiviral drug favipiravir will be available in the Indian market under the brand name FabiFlu at Rs 103 for a tablet from Glenmark Pharma that ...
Read more: Glenmark drug for mild Covid patients hits market, priced at Rs 103 a pill

Pharma Reviews: Disney+ Hotstar India appoints Sunil Rayan as president, head

The drug firm had successfully developed the active pharmaceutical ingredient (API) and the formulation for FabiFlu through its in-house R&D team. It ...
Read more: Disney+ Hotstar India appoints Sunil Rayan as president, head

Pharma Reviews: Every innovation has to benefit mankind at large

Could this be a cause for alarm for the Indian pharma industry? You have to agree, it is all changing dynamics. But think about India's situation 15-20 ...
Read more: Every innovation has to benefit mankind at large

Pharma Reviews: Vaccines Have Always Encountered Resistance Before Wide Acceptance

The rapid growth of the Indian pharmaceutical industry has gone a long way in according both respectability and acceptability to vaccines. In fact with ...
Read more: Vaccines Have Always Encountered Resistance Before Wide Acceptance

Pharma Reviews: Piramal Pharma Solutions to acquire G&W Laboratories' drug manufacturing facility in US

The Mumbai-based drug firm had on Friday received manufacturing and marketing approval from the Drugs Controller General of India (DCGI).
Read more: Piramal Pharma Solutions to acquire G&W Laboratories' drug manufacturing facility in US

Pharma Reviews: Indian healthcare ecosystem takes an integrated approach to fight COVID-19 : Prof. NK Ganguly ...

Pharmaceutical Companies have ensured uninterrupted supply of medicines and are ramping up their manufacturing capacity to meet the non-COVID ...
Read more: Indian healthcare ecosystem takes an integrated approach to fight COVID-19 : Prof. NK Ganguly ...

Pharma Reviews: Will boycott China work? Here's what the numbers say

According to data from nseinfobase.com of Prime Database, the market ... Indian pharma is heavily dependent on China as it imports two-thirds of its ...
Read more: Will boycott China work? Here's what the numbers say

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup June 19, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup June 19, 2020

Pharma Reviews: Stopping China imports may hurt India's edge, exports: telcos, pharma companies

Stopping China imports may hurt India's edge, exports: telcos, pharma companies. China accounts for around 14 per cent of India's imports, with major ...
Read more: Stopping China imports may hurt India's edge, exports: telcos, pharma companies

Pharma Reviews: India now faces threat of Chinese cyberattacks

Several government agencies, media houses, pharma companies, telecom operators and a large tyre company in India may be targeted by a massive ...
Read more: India now faces threat of Chinese cyberattacks

Pharma Reviews: Indian pharma's Chinese inventory costs rise 10%

Those supplying to the domestic market say leading Indian pharma companies have, depending on the segment that they cater to, have seen 10 to 15 ...
Read more: Indian pharma's Chinese inventory costs rise 10%

US FDA News: Certain COVID-19 Serology/Antibody Tests Should Not Be Used - Letter to Clinical Laboratory Staff and Health Care Providers

FDA warns lab staff and health care providers about using certain COVID-19 Serology/Antibody Tests.
Read more: Certain COVID-19 Serology/Antibody Tests Should Not Be Used - Letter to Clinical Laboratory Staff and Health Care Providers

Pharma Reviews: Renaissance in Ayurveda

The framework for health and medical care system in India was designed by ... perceived as a marketing opportunity by the Ayurveda pharma industry.
Read more: Renaissance in Ayurveda

Pharma Reviews: Indian companies to woo Central American nations in post COVID era; Virtual expo to be held for ...

The focus will be on critical sectors which have good potential and relevant to the region including Pharmaceuticals, Pharma Machinery & Technology; ...
Read more: Indian companies to woo Central American nations in post COVID era; Virtual expo to be held for ...

Pharma Reviews: Patents or people: The conundrum of healthcare industry

The pharma industry invests billions of dollars in the development of ... Generic drugs of Indian companies made them available at US$ 200-250 per ...
Read more: Patents or people: The conundrum of healthcare industry

Pharma Reviews: Sridhar Sivaram Says Stay Away From NBFCs, Consider Auto, Telecom

India's pharmaceutical sector has stock-specific opportunities, Sivaram said. Opportunity more on chemistry side than pharma side. See slower growth ...
Read more: Sridhar Sivaram Says Stay Away From NBFCs, Consider Auto, Telecom

Pharma Reviews: Six Things To Know About India-China Economic Relations

India's pharmaceutical industry is the third largest in the world in by volume and ranks 14 by value. The country exported medicines worth over $14 ...
Read more: Six Things To Know About India-China Economic Relations

Pharma Reviews: Govt bulk drug scheme may allow exports, too

India's pharmaceutical industry is the third largest in the world and relies on China for crucial raw material to make drugs. NEW DELHI: The government ...
Read more: Govt bulk drug scheme may allow exports, too

US FDA News: GSK Consumer Healthcare Issues Voluntary Nationwide Recall of Children's Robitussin® Honey Cough and Chest Congestion DM and Children's Dimetapp® Cold and Cough Due to Dosing Cups Missing Some Graduation Markings

GSK Consumer Healthcare is voluntarily recalling to the retail level two lots (listed below) of Children’s Robitussin® Honey Cough and Chest Congestion DM and one lot of Children’s Dimetapp® Cold and Cough, due to the inclusion of incorrect dosing cups.
Read more: GSK Consumer Healthcare Issues Voluntary Nationwide Recall of Children's Robitussin® Honey Cough and Chest Congestion DM and Children's Dimetapp® Cold and Cough Due to Dosing Cups Missing Some Graduation Markings

Pharma Reviews: Covid-19 crisis: Made-in-India remdesivir may come by end of June

Domestic pharmaceutical companies claim India is fully vertically integrated to make ... “The drug is available in the Indian market unfortunately.
Read more: Covid-19 crisis: Made-in-India remdesivir may come by end of June

Pharma Reviews: Mapping China's large trade footprint in India

China is India's largest trading partner, but the latter runs a large trade deficit. ... pharmaceutical ingredients), the backbone of India's pharma industry.
Read more: Mapping China's large trade footprint in India

Pharma Reviews: Strategic short term measures needed on the API front: Pharma experts

The Indian pharma industry, which is considerably dependent on China for the import of active pharmaceutical ingredients (APIs), may get adversely ...
Read more: Strategic short term measures needed on the API front: Pharma experts

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup June 18, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup June 18, 2020

US FDA News: Coronavirus (COVID-19) Update: FDA Takes Additional Action to Harness Real-World Data to Inform COVID-19 Response Efforts

FDA Takes Additional Action to Harness Real-World Data to Inform COVID-19 Response Efforts
Read more: Coronavirus (COVID-19) Update: FDA Takes Additional Action to Harness Real-World Data to Inform COVID-19 Response Efforts

US FDA News: FDA Approves First Therapy for Rare Disease that Causes Low Phosphate Blood Levels, Bone Softening

The FDA has approved Crysvita (burosumab-twza) injection to treat patients age two and older with tumor-induced osteomalacia (TIO), a rare disease that is characterized by the development of tumors that cause weakened and softened bones.
Read more: FDA Approves First Therapy for Rare Disease that Causes Low Phosphate Blood Levels, Bone Softening

US FDA News: FDA Takes Additional Action to Harness Real-World Data to Inform COVID-19 Response Efforts

FDA Takes Additional Action to Harness Real-World Data to Inform COVID-19 Response Efforts
Read more: FDA Takes Additional Action to Harness Real-World Data to Inform COVID-19 Response Efforts

Pharma Reviews: Roche Pharma India expands partnership with Cipla for key oncology medicines

This deal will ensure that the company's focus on providing Roche innovations in India remains steadfast in this portfolio and it will keep on collaborating ...
Read more: Roche Pharma India expands partnership with Cipla for key oncology medicines

Pharma Reviews: Indian drug firms cheer dexamethasone efficacy on severe COVID-19 patients

MUMBAI: Domestic drug manufacturers are bracing for an increase in the prices of active pharmaceutical ingredients (APIs) that go into the ...
Read more: Indian drug firms cheer dexamethasone efficacy on severe COVID-19 patients

Pharma Reviews: Stringent moisture control is a must for Pharmaceuticals : Deepak Pahwa

The pharmaceutical industry is all the more cautious. ... Now we are seeing Indian pharma companies ship to US and all major countries across the ...
Read more: Stringent moisture control is a must for Pharmaceuticals : Deepak Pahwa

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup June 17, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup June 17, 2020

US FDA News: Coronavirus (COVID-19) Update: FDA Issues Warning Letters to Companies Inappropriately Marketing Antibody Tests, Potentially Placing Public Health at Risk

The U.S. Food and Drug Administration has issued warning letters to three companies for marketing adulterated and misbranded COVID-19 antibody tests.
Read more: Coronavirus (COVID-19) Update: FDA Issues Warning Letters to Companies Inappropriately Marketing Antibody Tests, Potentially Placing Public Health at Risk

Pharma Reviews: No shortage of dexamethasone in India, Chinese raw materials remain key

According to Sudarshan Jain, Secretary General of Indian Pharmaceutical Alliance, Zydus Cadila has 83 percent market share for the drug. Jain said ...
Read more: No shortage of dexamethasone in India, Chinese raw materials remain key

Pharma Reviews: Slideshow | Gainers & Losers: 10 stocks that moved the most on June 16

According to Sudarshan Jain, Secretary General of Indian Pharmaceutical Alliance, Zydus Cadila has 83 percent market share for the drug. Jain said he ...
Read more: Slideshow | Gainers & Losers: 10 stocks that moved the most on June 16

Pharma Reviews: Lifesaving coronavirus drug Dexamethasone costs less than 30 paise; 20 cos sell in India

Most of the manufacturers have active pharmaceutical ingredient(API) making capabilities and there are many small and medium scale domestic API ...
Read more: Lifesaving coronavirus drug Dexamethasone costs less than 30 paise; 20 cos sell in India

Pharma Reviews: DGTR may take final call on anti-dumping duty on ciprofloxacin hydrochloride from China

This is considerably hurting the domestic pharmaceutical industry," a ... This has caused considerable losses to the Indian pharma industry.
Read more: DGTR may take final call on anti-dumping duty on ciprofloxacin hydrochloride from China

Pharma Reviews: Mega Flagship Event Of SPDS – DRPI ONLINE 2020 Attended By Pharma Professionals & Academia

Society for Pharmaceutical Dissolution Sciences (SPDS) in collaboration ... from professionals & experts from Indian & Global Industry &Academia.
Read more: Mega Flagship Event Of SPDS – DRPI ONLINE 2020 Attended By Pharma Professionals & Academia

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup June 16, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup June 16, 2020

US FDA News: Coronavirus (COVID-19) Update: Facilitating Diagnostic Test Availability for Asymptomatic Testing and Sample Pooling

Today, the FDA posted template updates on the validation of molecular diagnostic tests for developers that intend their assay to be used for pooling patient samples or for screening asymptomatic individuals not suspected of having COVID-19.
Read more: Coronavirus (COVID-19) Update: Facilitating Diagnostic Test Availability for Asymptomatic Testing and Sample Pooling

US FDA News: Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chembio Antibody Test

Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) of the Chembio Diagnostic System, Inc. (Chembio) DPP COVID-19 IgM/IgG System, a SARS-CoV-2 antibody test, due to performance concerns with the accuracy of the test.
Read more: Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chembio Antibody Test

Pharma Reviews: China tensions may boost domestic manufacturing

In certain sectors such as pharma, India is overwhelmingly dependent on China, with 75% of domestic supplies of raw materials sourced from there.
Read more: China tensions may boost domestic manufacturing

Pharma Reviews: China dumping key medicine in India

... China is dumping a key medicine -- ciprofloxacin hydrochloride -- below cost in the Indian market and hurting the domestic pharmaceutical industry, ...
Read more: China dumping key medicine in India

US FDA News: FDA Approves First Treatment for Adult Onset Still’s Disease, a Severe and Rare Disease

FDA approved Ilaris (canakinumab) injection for the treatment of Active Still’s disease, including Adult-Onset Still’s Disease (AOSD). Ilaris was previously approved for Systemic Juvenile Idiopathic Arthritis (SJIA) in patients aged 2 years and older.
Read more: FDA Approves First Treatment for Adult Onset Still’s Disease, a Severe and Rare Disease

Pharma Reviews: BQuick On June 16: Top 10 Stories In Under 10 Minutes

A mix of energy and pharma stocks is likely to be included among India's top 100 companies by market value, while select financials may be excluded ...
Read more: BQuick On June 16: Top 10 Stories In Under 10 Minutes

Pharma Reviews: Zydus Cadila gets USFDA approval to market generic version of Deferasirox tablets

The Hyderabad headquartered drug maker will obtain technology transfer from Gilead for manufacturing of the drug wherein the Indian firm would need ...
Read more: Zydus Cadila gets USFDA approval to market generic version of Deferasirox tablets

US FDA News: FDA Warns Four Manufacturers of Unapproved Injectable Drugs Labeled as Homeopathic

The FDA has issued warning letters to four companies for selling unapproved injectable homeopathic drugs that pose significant risks to patient health and violate federal law.
Read more: FDA Warns Four Manufacturers of Unapproved Injectable Drugs Labeled as Homeopathic

Pharma Reviews: Pharma exports record sterling performance in May 2020: Pharmexcil

Exports in the pharma sector had decreased in February and March, ... And the Indian pharma industry expresses its gratitude to Piyush Goyal, ...
Read more: Pharma exports record sterling performance in May 2020: Pharmexcil

Pharma Reviews: India is key to the global battle against Covid-19

Our foundation is also working with Indian pharma companies to look at the potential of transferring production techniques for drugs created by US ...
Read more: India is key to the global battle against Covid-19

Pharma Reviews: India, US need concerted efforts to advance business, people-to-people linkages post COVID-19 ...

Indian pharma companies, which are world leaders in affordable low-cost medicines and vaccines, are also collaborating with them in vaccine ...
Read more: India, US need concerted efforts to advance business, people-to-people linkages post COVID-19 ...

Pharma Reviews: Indian Army has killed 5 china army and 18 injured china army has started clashes its 2020 India ...

I have a Pharma business in Gujarat and I can tell that Our 80% Raw materials for the pharmaceutical Industry are imported from the China..If China ...
Read more: Indian Army has killed 5 china army and 18 injured china army has started clashes its 2020 India ...

Pharma Reviews: India, US need concerted efforts to advance business, people-to-people linkages post COVID-19 ...

With presence in diverse sectors, like IT, pharma, manufacturing, automotive, energy, defence etc, these companies have invested close to USD 22 ...
Read more: India, US need concerted efforts to advance business, people-to-people linkages post COVID-19 ...

Pharma Reviews: Stock Market Live: Sensex, Nifty off day's high; media index surges over 3%, JSW Steel top gainer

Stock Market Live: The Indian market traded higher on Tuesday on strong global cues after ... Alembic Pharma's shares surge 6%, hit 52- week high.
Read more: Stock Market Live: Sensex, Nifty off day's high; media index surges over 3%, JSW Steel top gainer

Product Recall Alerts: 6 recent drug, device recalls

Apotex recalls diabetes drug after FDA alert ... based Acella Pharmaceuticals recalled 13 lots of NP Thyroid after finding the drug to be super-potent.
Read more: 6 recent drug, device recalls

US FDA News: Coronavirus (COVID-19) Update: Daily Roundup June 15, 2020

Coronavirus (COVID-19) Update: Daily Roundup
Read more: Coronavirus (COVID-19) Update: Daily Roundup June 15, 2020

US FDA News: Remdesivir by Gilead Sciences: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of Treatment

FDA is warning health care providers that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended as it may result in reduced antiviral activity of remdesivir.
Read more: Remdesivir by Gilead Sciences: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of Treatment

US FDA News: Coronavirus (COVID-19) Update: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use

FDA is warning about a potential drug interaction with remdesivir, which received emergency use authorization to treat hospitalized COVID-19 patients with severe disease.
Read more: Coronavirus (COVID-19) Update: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use

Pharma Reviews: Reaching a USD 120 Billion Industry in Ten Years and Transforming into the Largest Market for ...

The Indian pharmaceutical industry is heavily import dependant for its key ... Pharma City provides an ideal blueprint for the API industry in India, ...
Read more: Reaching a USD 120 Billion Industry in Ten Years and Transforming into the Largest Market for ...

US FDA News: FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD

FDA permits marketing of the first game-based digital therapeutic device to improve attention function in children with ADHD. The game-based device, EndeavorRx, is for pediatric patients ages 8 to12 years old with primarily inattentive or combined-type ADHD
Read more: FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD

US FDA News: Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine

Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine
Read more: Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine

Pharma Reviews: Chinese pharma suppliers raise prices by 20%

Indian pharma companies now confront a new challenge as the cost of ... extensively by the pharma industry and also by the makers of sanitisers.
Read more: Chinese pharma suppliers raise prices by 20%

Pharma Reviews: Here's how govt wants Indian pharma replace Chinese imports

The operational details, shared with the CEOs of pharmaceutical companies on June 13 indicate that PLI scheme meant to make India Atma Nirhbar ...
Read more: Here's how govt wants Indian pharma replace Chinese imports

Pharma Reviews: Stock Market Highlights: Market recovers sharply to end higher led by auto stocks; M&M, Bharti ...

Stock Market Highlights: The Indian equity benchmark indices, Sensex and Nifty recovered from day's low to end higher in the final ... COVID no reason to be bullish on pharma; choose beaten down stocks with a plan: Samir Arora.
Read more: Stock Market Highlights: Market recovers sharply to end higher led by auto stocks; M&M, Bharti ...

Pharma Reviews: Companies need to design digital products with Netflix, Amazon-like approaches

Indian Pharmaceutical Alliance (IPA) and Boston Consulting Group (BCG) ... that will see major transformations in healthcare/ pharma companies?
Read more: Companies need to design digital products with Netflix, Amazon-like approaches

Pharma Reviews: Career in Pharmaceutical sector: Check scope, eligibility criteria and other details

The Pharmaceutical Sector is growing at a consistent rate in India and ... Amidst this gloomy situation prevailing in the world, Indian Pharmaceutical ...
Read more: Career in Pharmaceutical sector: Check scope, eligibility criteria and other details

Pharma Reviews: 6 Indian Firms To Boost Supply Of Remdesivir By Gilead

... Indian pharmaceutical companies to boost the supply of remdesivir, the experimental antiviral drug that has shown promise in Covid-19 treatment.
Read more: 6 Indian Firms To Boost Supply Of Remdesivir By Gilead